Kelly O’Grady, chief host & correspondent for dot.LA speaks with Kendall Bird and Sage Grazer, co-founders of mental wellness network, Frame, which seeks to help people find a form of therapy and a therapist.

On July 13, 2020 Techstars LA announced the ten startups that will make up its 2020 class, the first cohort to go remote due to COVID-19. Ben Bergman from dot.La, reports on how Techstars LA is evolving their programming to adjust to these challenging times.

In this episode of Fundraising Radio, BioscienceLA CEO David J. Whelan explains how founders working in bioscience and health tech can use this pandemic to their advantage during their fundraising and how other founders should adjust.

Rachel Uranga of dot.LA reports that Kernel announced Thursday it's raised $53 million in a Series C round led by General Catalyst with other investors including Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Kernel founder and CEO Bryan Johnson. Kernel is working to make the human brain, with all this inner workings, easy to read.

On July 8, 2020, Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced via Business Wire that the companies have entered into a collaboration and license agreement to research, develop and commercialize T cell engaging bispecific antibodies as potential therapeutics in oncology.